PROCEPT BioRobotics Corporation (PRCT) Tops Q3 EPS by 2c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q3 EPS of ($0.51), $0.02 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $35.1 million versus the consensus estimate of $33.44 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c